- Home
- JFBR vs GLMD Comparison
JFBR vs GLMD Comparison
Compare JFBR & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JFBR
- GLMD
- Stock Information
- Founded
- JFBR 2017
- GLMD 2000
- Country
- JFBR Israel
- GLMD Israel
- Employees
- JFBR N/A
- GLMD N/A
- Industry
- JFBR Other Specialty Stores
- GLMD Biotechnology: Pharmaceutical Preparations
- Sector
- JFBR Consumer Discretionary
- GLMD Health Care
- Exchange
- JFBR Nasdaq
- GLMD Nasdaq
- Market Cap
- JFBR 2.6M
- GLMD 3.0M
- IPO Year
- JFBR 2022
- GLMD 2014
- Fundamental
- Price
- JFBR $0.46
- GLMD $1.51
- Analyst Decision
- JFBR
- GLMD Hold
- Analyst Count
- JFBR 0
- GLMD 1
- Target Price
- JFBR N/A
- GLMD N/A
- AVG Volume (30 Days)
- JFBR 3.1M
- GLMD 255.6K
- Earning Date
- JFBR 06-17-2025
- GLMD 06-17-2025
- Dividend Yield
- JFBR N/A
- GLMD N/A
- EPS Growth
- JFBR N/A
- GLMD N/A
- EPS
- JFBR N/A
- GLMD N/A
- Revenue
- JFBR $13,688,000.00
- GLMD N/A
- Revenue This Year
- JFBR N/A
- GLMD N/A
- Revenue Next Year
- JFBR N/A
- GLMD N/A
- P/E Ratio
- JFBR N/A
- GLMD N/A
- Revenue Growth
- JFBR 36.77
- GLMD N/A
- 52 Week Low
- JFBR $0.38
- GLMD $1.15
- 52 Week High
- JFBR $6.76
- GLMD $23.80
- Technical
- Relative Strength Index (RSI)
- JFBR 36.22
- GLMD 56.28
- Support Level
- JFBR $0.39
- GLMD $1.36
- Resistance Level
- JFBR $0.50
- GLMD $1.60
- Average True Range (ATR)
- JFBR 0.10
- GLMD 0.09
- MACD
- JFBR 0.00
- GLMD 0.03
- Stochastic Oscillator
- JFBR 19.03
- GLMD 79.07
About JFBR Jeffs' Brands Ltd
Jeffs Brands Ltd is an e-commerce CPG company, operating on Amazon. The company serves as the holding company of other e-commerce companies, Smart Repair Pro, Purex, and Top Rank, that operate online stores for the sale of various consumer products on Amazon online marketplace, utilizing the FBA model. The company has five wholly-owned subsidiaries: Smart Repair Pro, Purex, Top Rank, Fort and Jeffs' Brands Holdings. The company also utilizes internal methodologies to analyze sales data and patterns on Amazon to identify existing stores, niches, and products that have the potential for development and growth, and for maximizing sales of existing proprietary products.
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.